TP53 and hepatocellular carcinoma: To further validate the results of network pharmacology and explore whether PGG promotes apoptosis in hepatocellular carcinoma pairs through activation of the p53 signaling pathway, an in vitro hepatocellular carcinoma model was established using HepG2 cells.